Gilead’s Remdesivir Brought In $873 Million During The Third Quarter

CNBC
By Staff of CNBC
Business News Television Channel •

Gilead reports quarterly earnings results.

Meg Tirrell joins ‘Closing Bell’ to talk about Gilead’s quarterly earnings.

STOCKS IN THIS ARTICLE

GILD
Track all markets on TradingView

More from this Author

Target’s Holiday-Quarter Sales And Store Traffic Drop, As Retailer Tries To Snap Its Slump

Target’s Holiday-Quarter Sales And Store Traffic Drop, As Retailer Tries To Snap Its Slump

CNBC •
Comcast Beats Earnings Estimates Despite More Broadband Subscriber Losses

Comcast Beats Earnings Estimates Despite More Broadband Subscriber Losses

CNBC •
GM Raises Guidance After Beating Wall Street Expectations, Lowering Tariff Costs

GM Raises Guidance After Beating Wall Street Expectations, Lowering Tariff Costs

CNBC •

Comments

Back to all articles